Loading…
Benitec Biopharma Inc. is projected to rise to $18.58 by 2027, a +38% move from its current price of $13.42. BNTC is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $13.05 | $13.43 | $13.81 | +0.06% |
| Jul 13 | $12.91 | $13.43 | $13.98 | +0.11% |
| Jul 14 | $12.80 | $13.44 | $14.11 | +0.17% |
| Jul 15 | $12.71 | $13.45 | $14.23 | +0.22% |
| Jul 16 | $12.64 | $13.46 | $14.33 | +0.28% |
| Jul 17 | $12.57 | $13.46 | $14.43 | +0.33% |
| Jul 18 | $12.50 | $13.47 | $14.51 | +0.39% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $12.50 | $13.47 | $14.51 | +0.39% |
| Week 2 | $12.17 | $13.52 | $15.03 | +0.78% |
| Week 3 | $11.93 | $13.58 | $15.45 | +1.17% |
| Week 4 | $11.74 | $13.63 | $15.82 | +1.56% |
| Week 5 | $11.58 | $13.68 | $16.16 | +1.95% |
| Week 6 | $11.44 | $13.73 | $16.49 | +2.35% |
| Week 7 | $11.32 | $13.79 | $16.79 | +2.74% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Benitec Biopharma Inc. is a clinical-stage biotechnology company focused on the development of novel genetic medicines. Its Silence and Replace platform combines RNA interference with gene therapy to create medicines that simultaneously silence disease-causing genes and deliver wildtype replacement genes after a single administration of the therapeutic construct.
The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.
Benitec Biopharma Inc. trades in the healthcare sector and currently has a price of $13.38 per share. Its market capitalization is $459.66M and the stock is ranked 3114 by market cap.
A major floor 31.1% below — a decisive break under it would weaken the trend.
The nearest floor, 22.6% below — buyers have tended to step in here.
Price is pressing into resistance (1.6% away) — a breakout level to watch.
A major ceiling 17.1% above — clearing it would confirm fresh momentum.
Key BNTC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BNTC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $13.40 | Buy | $13.37 | Buy |
| MA 10 | $13.14 | Buy | $13.15 | Buy |
| MA 20 | $12.59 | Buy | $12.71 | Buy |
| MA 50 | $11.89 | Buy | $12.18 | Buy |
| MA 100 | $11.73 | Buy | $12.07 | Buy |
| MA 200 | $12.51 | Buy | $12.19 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 60.83 | Neutral |
| Stoch RSI (14) | 33.21 | Neutral |
| CCI (20) | 74.37 | Neutral |
| Williams %R (14) | -15.79 | Info |
| MACD (12,26,9) | 0.07 | Buy |
| ROC (12) | 4.19 | Buy |
| Bollinger %B (20,2) | 0.74 | Neutral |
| Stochastic %K (14) | 84.21 | Sell |
| TRIX (15) | 0.56 | Buy |
| Awesome (5,34) | 1.47 | Buy |
| Ultimate (7,14,28) | 55.38 | Neutral |
| Momentum (10) | 0.42 | Buy |
| Aroon Osc (25) | 36.00 | Buy |
| Hull MA (9) | 13.59 | Sell |
| ADX (14) | 18.99 | Neutral |
| ATR (14) | 0.32 | Info |
The 30-day technical picture is bullish. The RSI14 is 60, and the 50-day simple moving average is $11.83 while the 200-day simple moving average is $12.53. Support is at $10.39 and resistance at $13.63. The 30-day price range extends from a low of $10.87 to a high of $16.48.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $10.06 | $13.42 | $19.25 | 0% | Neutral | |
| $14.75 | $18.58 | $24.79 | +38% | Bullish | |
| $19.79 | $25.67 | $35.57 | +91% | Bullish | |
| $22.06 | $29.30 | $41.84 | +118% | Bullish | |
| $22.61 | $30.67 | $44.89 | +129% | Bullish | |
| $26.60 | $36.79 | $55.03 | +174% | Bullish | |
| $27.42 | $38.60 | $58.89 | +188% | Bullish | |
| $28.71 | $41.11 | $63.82 | +206% | Bullish | |
| $36.58 | $53.23 | $84.00 | +297% | Bullish | |
| $42.49 | $62.79 | $100.58 | +368% | Bullish | |
| $56.01 | $88.76 | $151.45 | +561% | Bullish | |
| $121.16 | $216.64 | $405.16 | +15.1x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $10.06 | $13.42 | $16.53 | +0.00% |
| August 2026 | $12.12 | $14.32 | $17.39 | +6.73% |
| September 2026 | $11.86 | $14.11 | $17.33 | -1.47% |
| October 2026 | $11.83 | $14.17 | $17.57 | +0.40% |
| November 2026 | $12.38 | $14.90 | $18.62 | +5.15% |
| December 2026 | $12.64 | $15.29 | $19.25 | +2.61% |
Click any year to see its month-by-month BNTC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The BNTC price prediction for 2026 points to an average of $13.42 (low $10.06, high $19.25) — a potential gain of 0% on today's $13.42. Price action looks broadly range-bound.
In 2027, BNTC is projected to trade between $14.75 and $24.79, averaging $18.58 — a potential gain of +38% from today's $13.42. That is up +38% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Benitec Biopharma Inc.'s 2028 outlook centres on $25.67, within a $19.79 to $35.57 range. That is up +38% on the projected 2027 average. That marks a +91% change versus current levels. Momentum favours further upside here.
By 2029, BNTC could reach as high as $41.84, with a base case around $29.30 and support toward $22.06 — roughly +118% from $13.42. Buyers look set to stay in control over this stretch.
Expect BNTC to range from $22.61 to $44.89 through 2030. The $30.67 average target implies a +129% move from current prices. That is up +5% on the projected 2029 average. Momentum favours further upside here.
The BNTC price prediction for 2031 points to an average of $36.79 (low $26.60, high $55.03) — a potential gain of +174% on today's $13.42. Buyers look set to stay in control over this stretch.
In 2032, BNTC is projected to trade between $27.42 and $58.89, averaging $38.60 — a potential gain of +188% from today's $13.42. That is up +5% on the projected 2031 average. Momentum favours further upside here.
Benitec Biopharma Inc.'s 2033 outlook centres on $41.11, within a $28.71 to $63.82 range. That is up +6% on the projected 2032 average. That marks a +206% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, BNTC could reach as high as $84.00, with a base case around $53.23 and support toward $36.58 — roughly +297% from $13.42. Momentum favours further upside here.
Expect BNTC to range from $42.49 to $100.58 through 2035. The $62.79 average target implies a +368% move from current prices. That is up +18% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The BNTC price prediction for 2040 points to an average of $88.76 (low $56.01, high $151.45) — a potential gain of +561% on today's $13.42. Momentum favours further upside here.
In 2050, BNTC is projected to trade between $121.16 and $405.16, averaging $216.64 — a potential gain of +15.1x from today's $13.42. That is up +144% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in BNTC today (≈ 74.515648 BNTC) could be worth
$16,142.8
+$15,142.8 (+1514%) by 2050 · US Dollar
Based on the average projected BNTC price of $216.64 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BNTCwould be worth at today's price.
$1,000 invested in BNTC on Jul 10, 2025 (≈ 72.516316 BNTC) would be worth
$973.17
-$26.83 (-2.7%) today · 0.97× · US Dollar
Based on a BNTC entry price of $13.79 vs. today's $13.42.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $13.22 | $1,015.13 | +1.5% |
| 1 month ago | $10.39 | $1,291.63 | +29.2% |
| 3 months ago | $11.42 | $1,175.13 | +17.5% |
| 6 months ago | $12.14 | $1,105.44 | +10.5% |
| 1 year ago | $13.79 | $973.17 | -2.7% |
| All time (5.0y) ago | $67.83 | $197.85 | -80.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BNTC forecast.
Our base-case forecast reaches $27.00 around 2029.
Implied market cap at $27.00: $927.57M
Multi-year forecasts show a bullish trajectory with rising averages and strong upside potential. For 2030, the average price is $33.24 with a maximum of $49.91 and a minimum of $23.95, yielding a projected ROI of 148.4% and bullish sentiment. In 2040, the average price is $104.56 with a maximum of $185.38 and a minimum of $62.93, yielding a projected ROI of 681.5% and bullish sentiment.
By 2050, the average price is $259.68 with a maximum of $508.08 and a minimum of $135.42, yielding a projected ROI of 1840.8% and bullish sentiment. These figures indicate a steadily rising long-term outlook, though these are estimates, not guarantees, and market conditions can affect outcomes.
Tap a question to reveal the answer.
2030 forecast: average price $33.24, minimum $23.95, maximum $49.91, ROI 148.4%, sentiment BULLISH.
Forecasts show bullish sentiment from 2027 onward, with key yearly averages such as 2027 $19.61, 2028 $27.71, 2029 $31.36 and 2030 $33.24, along with rising longer-term targets (2040 $104.56, 2050 $259.68). These are estimates, not guarantees.
Yes, the 2030 max is $49.91, and the 2031 max is $62.75, with 2032 max $65.80, 2033 max $72.76 and 2034 max $100.63.
Current price is $13.38 and market cap is $459.66M.
2040 forecast: average price $104.56, minimum $62.93, maximum $185.38, ROI 681.5%, sentiment BULLISH.
Benitec Biopharma Inc. Community Discussion
0Share your Benitec Biopharma Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.